The finance handoff at FuelCell Energy (NASDAQ:FCEL) drew a rougher verdict. It is drawing a far rougher market verdict than ...
A randomized phase 2B trial of a novel peptide-based vaccine missed its primary endpoint, as the immunotherapy failed to ...
Researchers at Fred Hutch Cancer Center have identified a previously overlooked molecular regulator that helps determine whether prostate tumors remain sensitive to treatment or evolve into a more ...
Anthropic recently disclosed five cases in which users hid their countries while asking Claude for help enhancing pathogens ...
Morning Overview on MSN
High-risk blood cancer stem cells lean on one molecule, and cutting it off weakens them
High-risk myelodysplastic syndrome, a bone marrow cancer that can turn into acute myeloid leukemia, is driven by stem cells that burn through an unusually large supply of one molecule: nicotinamide ...
Massive Entertainment has become its own business unit with Ubisoft, leading The Division, Ghost Recon and Splinter Cell.
The early-month blues: "It's turned into #### again"On the morning of the first of the month, the moment you press the ...
Agilent Technologies has launched the NovoStation Sample Preparation System, an automated platform designed to cut manual ...
Memory stocks selloff deepened Wednesday as Micron Technology faced a Taiwan union strike vote, Toshiba announced a $380 ...
When Dr. Kourosh Parham conceived a first-of-its-kind blood test for tinnitus, he knew further research was needed to confirm ...
Deep inside every cell, the endoplasmic reticulum works as the cellular factory where newly made proteins are folded, checked ...
A paper has been published on the creation of a disease model for multiple sclerosis using organoids. I am introducing this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results